LE051
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LE051, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy [EARLY_Phase 1]